Immunic Inc. Common Stock (IMUX)
Stock · NASDAQ · Health Care
$15.4as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$11.73
Industry
Biotechnology: Pharmaceutical Preparations
About IMUX
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 100
- Website
- imux.com
Fundamentals
- 1-day range
- $15.05$16.3
- Market cap
- $192.06M
- P/E (trailing)
- —
- P/E (forward)
- -6.15
- EPS (trailing)
- $-5.42
- Dividend yield
- —
- Beta
- 1.42
- Avg. volume
- 186.7K
- Dividend pay date
- April 15, 2019
52-week range
$5.06$17.43
Next earnings: November 12, 2026 · EPS estimate $-1.00
Forecasts
11 analyst ratings
Buy 94%
Hold 6%
Sell 0%
1-year price forecast
High
$85
+451.9%
Median
$30
+94.8%
Low
$19
+23.4%
Immunic Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IMUXImmunic Inc. Common Stock$15.4▼ 5.52%Market cap $192.06MP/E —$5.06$17.43
- NBPNovaBridge Biosciences American Depositary Shares$1.85▼ 2.38%Market cap $185.76MP/E —$1.46$6.79
- GLSIGreenwich LifeSciences Inc. Common Stock$15.67▼ 16.34%Market cap $198.74MP/E —$7.78$34.1
- KROSKeros Therapeutics Inc. Common Stock$11.05▼ 1.60%Market cap $200.10MP/E —$9.69$22.55
- MSLESatellos Bioscience Inc. Common Stock$8.92▼ 7.23%Market cap $203.94MP/E —$7.08$18.98
- EVOEvotec SE American Depositary Shares$1.91▼ 2.80%Market cap $172.06MP/E —$3.18$7.3
- WHWKWhitehawk Therapeutics Inc. Common Stock$4.65▼ 4.52%Market cap $212.98MP/E —$1.76$5.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IMUX Immunic Inc. Common Stock | $192.06M | — | $15.4 | ▼ 5.52% | $5.06$17.43 |
| NBP NovaBridge Biosciences American Depositary Shares | $185.76M | — | $1.85 | ▼ 2.38% | $1.46$6.79 |
| GLSI Greenwich LifeSciences Inc. Common Stock | $198.74M | — | $15.67 | ▼ 16.34% | $7.78$34.1 |
| KROS Keros Therapeutics Inc. Common Stock | $200.10M | — | $11.05 | ▼ 1.60% | $9.69$22.55 |
| MSLE Satellos Bioscience Inc. Common Stock | $203.94M | — | $8.92 | ▼ 7.23% | $7.08$18.98 |
| EVO Evotec SE American Depositary Shares | $172.06M | — | $1.91 | ▼ 2.80% | $3.18$7.3 |
| WHWK Whitehawk Therapeutics Inc. Common Stock | $212.98M | — | $4.65 | ▼ 4.52% | $1.76$5.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 953.0K
- Total value held
- $1.06M
- Institutional holders
- 3
Top holders this quarter
- Unknown953.0K
- Unknown3
- Unknown2
See the full, filterable feed with live charts on the MarketWall dashboard.